Stockscreener 앱 받기
16.15
0.09%
0.010
전일 마감가:
$16.14
열려 있는:
$16.13
하루 거래량:
33.54M
Relative Volume:
1.02
시가총액:
$31.00B
수익:
$15.14B
순이익/손실:
$1.42B
주가수익비율:
21.94
EPS:
0.7361
순현금흐름:
$1.63B
1주 성능:
+11.34%
1개월 성능:
+2.18%
6개월 성능:
-32.63%
1년 성능:
-29.88%
1일 변동 폭
$15.97
$16.43
1주일 범위
$14.02
$17.18
52주 변동 폭
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
명칭
Kenvue Inc
전화
908-874-1200
주소
1 KENVUE WAY, SUMMIT
KVUE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
16.16 | 30.92B | 15.14B | 1.42B | 1.63B | 0.7361 |
|
PG
Procter Gamble Co
|
146.43 | 345.88B | 84.93B | 16.86B | 14.94B | 6.8506 |
|
UL
Unilever Plc Adr
|
60.67 | 148.76B | 64.99B | 6.71B | 6.53B | 2.4355 |
|
CL
Colgate Palmolive Co
|
75.62 | 60.44B | 20.10B | 3.04B | 3.37B | 3.569 |
|
KMB
Kimberly Clark Corp
|
100.09 | 33.94B | 18.08B | 1.81B | 2.10B | 5.904 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2025-09-26 | 업그레이드 | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | 개시 | Redburn Atlantic | Neutral |
| 2025-03-24 | 개시 | Evercore ISI | In-line |
| 2025-01-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-09-24 | 개시 | Jefferies | Buy |
| 2024-09-24 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | 재개 | Citigroup | Neutral |
| 2024-04-11 | 개시 | Bernstein | Underperform |
| 2024-04-03 | 개시 | William Blair | Mkt Perform |
| 2024-03-01 | 재개 | Goldman | Neutral |
| 2023-11-17 | 개시 | Piper Sandler | Neutral |
| 2023-09-11 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2023-09-07 | 개시 | Canaccord Genuity | Buy |
| 2023-09-06 | 개시 | Argus | Hold |
| 2023-08-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-25 | 개시 | Edward Jones | Buy |
| 2023-06-01 | 개시 | HSBC Securities | Hold |
| 2023-05-30 | 개시 | BofA Securities | Buy |
| 2023-05-30 | 개시 | Citigroup | Neutral |
| 2023-05-30 | 개시 | Deutsche Bank | Hold |
| 2023-05-30 | 개시 | Exane BNP Paribas | Neutral |
| 2023-05-30 | 개시 | Goldman | Neutral |
| 2023-05-30 | 개시 | JP Morgan | Overweight |
| 2023-05-30 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 개시 | UBS | Neutral |
모두보기
Kenvue Inc 주식(KVUE)의 최신 뉴스
Why is Kimberly-Clark hoping to acquire the embattled maker of Tylenol? - marketplace.org
Kimberly-Clark, Kenvue’s $48.7B deal among recent multibillion-dollar M&A - Manufacturing Dive
These Hedge Funds Benefit From Kenvue Deal - Institutional Investor
The Gamble Behind a Big Takeover of Tylenol’s Maker - The New York Times
Kimberly-Clark: Can The Kenvue Acquisition Erase The Decade Of Disappointment? (KMB) - Seeking Alpha
Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal - 101.3 KFDI
Kimberly-Clark acquires Kenvue for USD 48.7 billion to strengthen its leadership in personal care and health - Tissue Online North America
Kimberly-Clark CEO Mike Hsu Bets on Growth with Kenvue Deal - Business Chief
Neutrogena maker Kenvue to be sold to Kimberly-Clark in $48.7 billion deal - Cosmetics Business
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn - Yahoo Finance
Kenvue Stock Rose 12% On Possible $48.7 Billion Acquisition by Kimberly-Clark - TIKR.com
Levin Capital Strategies L.P. Buys New Shares in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Shares Sold by Bank of New York Mellon Corp - MarketBeat
Kimberly-Clark To Acquire Kenvue In $48.7 Billion Mega Deal - Yahoo Finance
Kenvue Inc. $KVUE Stake Reduced by South Dakota Investment Council - MarketBeat
Kenvue: Q3 Earnings Snapshot - New Haven Register
Kimberly-Clark Stock Drops Premarket Even As Analysts, Retail Investors Turn Positive On $49B Kenvue Deal - Stocktwits
Kimberly-Clark to acquire Tylenol's parent company in nearly $49B deal - NPR
Is now a turning point for Kenvue Inc.Quarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
Real time scanner hits for Kenvue Inc. explainedForecast Cut & AI Forecast Swing Trade Picks - newser.com
These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors? - AOL.com
Predicting Kenvue Inc. trend using moving averages2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - newser.com
21,714 Shares in Kenvue Inc. $KVUE Acquired by World Investment Advisors - MarketBeat
Kimberly-Clark to buy Kenvue - The Arkansas Democrat-Gazette
These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors? - The Motley Fool
Will Kenvue Inc. stock outperform small cap peersJuly 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Order flow analysis tools used on Kenvue Inc.2025 Dividend Review & Stepwise Trade Execution Plans - newser.com
What Next for Kenvue’s Beauty Brands? - The Business of Fashion
Kenvue Fails To Deliver After Launch Expected To Drive Iconic Brands To New Heights - Citeline News & Insights
Using R and stats models for Kenvue Inc. forecastingWatch List & High Accuracy Swing Entry Alerts - newser.com
Decoding Kenvue Inc (KVUE): A Strategic SWOT Insight - GuruFocus
Kimberly-Clark is taking Tylenol in $49 billion deal - Morning Brew
Kenvue’s Tylenol Litigation Overhang Doesn’t Dim ‘Generational Opportunity’ For Kimberly-Clark - Citeline News & Insights
Tylenol maker Kenvue secures deal from consumer goods giant - Yahoo Finance
Kimberly-Clark Bets $50 Billion On Health And Beauty With Kenvue Deal - Finimize
Latham Advises on Financing for Kimberly-Clark’s Acquisition of Kenvue to Create a US$32 Billion Global Health and Wellness Leader - Legal Desire Media and Insights
Tylenol’s parent company will combine with the maker of Huggies in a $48.7 billion mega-deal - WQOW
Why Tylenol Maker Kenvue Stock Just Popped - AOL.com
Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc.KVUE - The AI Journal
Buy Rating on Kenvue, Inc.: Promising Investment Amid Acquisition and Legal Challenges - TipRanks
Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient' - CNBC
Kimberly-Clark to Acquire Kenvue - WWD
North Texas’ Kimberly-Clark To Acquire Tylenol Maker in $40B Deal - Dallas Innovates
Factbox-Kenvue’s legal risks loom over planned acquisition by Kimberly-Clark - Yahoo Finance
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm - The New York Times
Factbox-Kenvue’s Legal Risks Loom Over Planned Acquisition by Kimberly-Clark - US News Money
Kimberly-Clark acquires Neutrogena-owner Kenvue - FashionNetwork USA
Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue - The Wall Street Journal
Markets News, Nov. 3, 2025: Dow Falters as Cloud Deals Boost Nasdaq; Kenvue Stock Soars on Kimberly-Clark Takeover - Investopedia
ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Kenvue Inc. - 富途牛牛
Kenvue: Takeover by Kimberly-Clark Gives Shareholders a Lifeline - Morningstar
Kenvue Inc (KVUE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.87%
0.41%
자본화:
|
볼륨(24시간):